Disease Info Card

Perineurioma

Information about Perineurioma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Perineurioma

Most recent studies have shown that Perineurioma shares some biological mechanisms with benign-neoplasm, hypertrophy, malignant-paraganglionic-neoplasm, malignant-peripheral-nerve-sheath-tumor, multiple-acyl-coenzyme-a-dehydrogenase-deficiency, neoplasms, nerve-sheath-tumors, neurilemmoma, neurofibroma, neurofibromatoses, neuroma, peripheral-nerve-sheath-neoplasm, peripheral-nervous-system-neoplasms, sarcoma, sclerosis, skin-neoplasms, soft-tissue-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Perineurioma, and have been seen in publications frequently: Cell Differentiation, Cell Growth, Cell Migration, Cell Proliferation, Drug Resistance, Interphase, Localization, Metaphase, Mitosis, Muscle Atrophy, Ossification, Pathogenesis, Pinocytosis, Reflex, Regeneration

Quite a number of genes have been found to play important roles in Perineurioma, such as B3GAT1, CALM2, CD34, CD99, CLDN1, CLDN7, DES, E2F6, ETFA, GFAP, KIT, MUC1, NF2, NFASC, S100A1, S100B, SLC2A1, SLC4A1, SLC4A3, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Perineurioma Related Genes

click to see detail information for each gene

B3GAT1 CALM2 CD34
CD99 CLDN1 CLDN7
DES E2F6 ETFA
GFAP KIT MUC1
NF2 NFASC S100A1
S100B SLC2A1 SLC4A1
SLC4A3 VIM